More than 96 percent of people develop coronavirus antibodies within 28-34 days of receiving the first dose of the AstraZeneca or Pfizer vaccine, new research that sampled more than 8000 participants, has revealed. The England- and Wales-based study also found that almost 100 percent of people develop immune cells to successfully fight off coronavirus after …

The post First dose of COVID-19 vaccine makes antibodies in 96% cases appeared first on The Filipino Times.